Active Biotech AB (publ) (LON:0GQU)

Active Biotech AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	-	-	-	-	-	6.73
Revenue Growth (YoY)	-	-	-	-	-	-20.18%
Gross Profit	-	-	-	-	-	6.73
Selling, General & Admin	12.57	13.17	13.94	15.06	15.25	13.48
Research & Development	27.77	26.67	32.54	42.82	34.54	25.55
Operating Expenses	40.34	39.84	46.48	57.89	49.78	39.03
Operating Income	-40.34	-39.84	-46.48	-57.89	-49.78	-32.31
Interest Expense	-0.18	-0.18	-0.24	-0.21	-0.03	-0.09
Interest & Investment Income	0.65	0.65	0.29	0.05	-	-
Currency Exchange Gain (Loss)	-0.03	-0.03	0.07	-0.01	0.02	-0.07
EBT Excluding Unusual Items	-39.9	-39.4	-46.37	-58.05	-49.79	-32.46
Gain (Loss) on Sale of Investments	-	-	0.57	-0.32	-0.03	0.22
Pretax Income	-39.9	-39.4	-45.8	-58.37	-49.83	-32.25
Net Income	-39.9	-39.4	-45.8	-58.37	-49.83	-32.25
Net Income to Common	-39.9	-39.4	-45.8	-58.37	-49.83	-32.25
Shares Outstanding (Basic)	608	420	272	234	214	169
Shares Outstanding (Diluted)	608	420	272	234	214	169
Shares Change (YoY)	107.64%	54.84%	16.21%	9.23%	26.87%	16.09%
EPS (Basic)	-0.07	-0.09	-0.17	-0.25	-0.23	-0.19
EPS (Diluted)	-0.07	-0.09	-0.17	-0.25	-0.23	-0.19
Free Cash Flow	-39.02	-40.42	-45.74	-54.85	-46.17	-32.22
Free Cash Flow Per Share	-0.06	-0.10	-0.17	-0.23	-0.22	-0.19
Gross Margin	-	-	-	-	-	100.00%
Operating Margin	-	-	-	-	-	-480.39%
Profit Margin	-	-	-	-	-	-479.48%
Free Cash Flow Margin	-	-	-	-	-	-479.05%
EBITDA	-38.74	-38.24	-44.78	-57.89	-48.48	-31.01
D&A For EBITDA	1.6	1.6	1.7	0	1.3	1.3
EBIT	-40.34	-39.84	-46.48	-57.89	-49.78	-32.31

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.